Standardizing work as a recursive process: Shaping the embryonic stem cell field

New Genetics and Society

Volumn 34, Issue 1, 2015, Pages 72-88

  Eriksson, Lena ^a   Webster, Andrew ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Bio objects; Standardization; Stem cells

Indexed keywords

ARTICLE; BIOTECHNOLOGY; CELL CULTURE; EMBRYO; EMBRYONIC STEM CELL; HEALTH CARE SYSTEM; HUMAN; HUMAN CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SCIENCE; STANDARD; STANDARDIZATION; STEM CELL; STEM CELL RESEARCH;

EID: 84922649689     PISSN: 14636778     EISSN: 14699915     Source Type: Journal    
DOI: 10.1080/14636778.2014.998818     Document Type: Article

References (42)

1. Amps, K., P.W. Andrews, A. Ford, P. J. Gokhale, and H. Moore. 2011. "Screening Ethnically Diverse Human Embryonic Stem Cells Identifies a Chromosome 20 Minimal Amplicon Conferring Growth Advantage." Nature Biotechnology 29 (12): 1132-1144.
2. Birke, L., A. Arluke, and M. Michael. 2007. The Sacrifice: How Scientific Experiments Transform Animals and People. West Lafayette, IN: Purdue University Press.
3. Bjornson, C. R., R. L. Rietze, B. A. Reynolds, M. C. Magli, and A. L. Vescovi. 1999. "Turning Brain into Blood: A Hematopoietic Fate Adopted by Adult Neural Stem Cells in Vivo." Science 283: 534-537.
4. Bowker, G., and S. Leigh Star. 1999. Sorting Things Out: Classification and Its Consequences. Cambridge, MA: MIT Press.
5. Brazelton, T. R., F. M. Rossi, G. I. Keshet, and H. M. Blau. 2000. "From Marrow to Brain: Expression of Neuronal Phenotypes in Adult Mice." Science 290: 1775-1779.
6. Busch, L. 2011. Standards: Recipes for Reality. Cambridge, MA: MIT Press.
7. Cambrosio, A., P. Keating, T. Schlich, and G. Weisz. 2006. "Regulatory Objectivity and the Generation and Management of Evidence in Medicine." Social Science and Medicine 63 (11): 189-199.
8. Clarke, D., C. B. Johansson, J. Wilbertz, B. Veress, E. Nilsson, and H. Karlström. 2000. "Generalized Potential of Adult Neural Stem Cells." Science 288: 1660-1663.
9. Disco, C., A. Rip, and B. van der Meulen. 1992. "Technical Innovation and the Universities: Division of Labour in Cosmopolitan Regimes." Social Science Information 31: 465-507.
10. Eriksson, L. 2012. "Pluripotent Promises: Configurations of a Bio-object." In Bio-Objects: Life in the 21st Century, edited by N. Vermeulen, S. Tamminen, and A. Webster, 27-42. Burlington, VT: Ashgate.
11. Eriksson, L., and A. Webster. 2008. "Standardizing the Unknown: Practicable Pluripotency as Doable Futures." Science as Culture 17 (1): 57-69.
12. Fujimura, J. 1987. "Constructing 'Do-Able' Problems in Cancer Research: Articulating Alignment." Social Studies of Science 17: 257-293.
13. Hauskeller, C., and S. Weber. 2011. "Framing Pluripotency: IPS Cells and the Shaping of Stem Cell Science." New Genetics and Society 30: 415-431.
14. Hogle, L. F. 2010. "Characterizing Human Embryonic Stem Cells: Biological and Social Markers of Identity." Medical Anthropology Quarterly 24: 433-450.
15. Holmberg, T., N. Schwennesen, and A. Webster. 2011. "Bio-Objects and the Bio-Objectification Process." Croatian Medical Journal 52 (6): 740-742.
16. Isasi, R. M., and B. M. Knoppers. 2009. "Towards Commonality? Policy Approaches to Human Embryonic Stem Cell Research in Europe." In Embryonic Stem Cell Patterns: European Law and Ethics, edited by A. Plomer and P. Torremans, 29-56. London: Oxford University Press.
17. Jasanoff, S. ed. 2011. Reframing Rights: Bioconstitutionalism in the genetic age. Cambridge, MA: MIT Press.
18. Keating, P., and A. Cambrosio. 2003. Biomedical Platforms. Cambridge, MA: MIT Press.
19. Keating, P., C. Limoges, and A. Cambrosio. 1999. "The Automated Laboratory: The Generation and Replication of Work in Molecular Genetics." In The Practices of Human Genetics, edited by M. Fortun and E. Mendelsohn, 125-142. Dordrecht: Springer.
20. Krause, D., N. D. Theise, M. I. Collector, O. Henegariu, S. Hwang, R. Gardner, S. Neutzel, and S. J. Sharks. 2001. "Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem Cell." Cell 105: 369-377.
21. Landecker, C. 2010. Culturing Life: How Cells Became Technologies. Cambridge, MA: Harvard University Press.
22. Latour, B. 1987. Science in Action. Cambridge, MA: Harvard University Press.
23. Lin, Y., D. J. Weisdorf, A. Solovey, and R. P. Hebbel. 2000. "Origins of Circulating Endothelial Cells and Endothelial Outgrowth from Blood." Journal of Clinical Investigation105: 71-77.
24. Maeseele, P., J. Allgaier, and L. Martinelli. 2013. "Bio-Objects and the Media: The Role of Communication in Bio-Objectification Processes." CMJ 54: 229-33.
25. Mason, C. 2006. "The Time Has Come to Engineer Tissues and Not Just Tissue Engineer." Regenerative Medicine 1 (3): 303-306.
26. Mason, C., D. A. Brindley, E. J. Culme-Seymour, and N. L. Davie. 2011. "Cell Therapy Industry: Billion Dollar Global Business with Unlimited Potential." Regenerative Medicine 6: 265-272.
27. Metzler, I., and A. Webster. 2011. "Bio-Objects and Their Boundaries: Governing Matters at the Intersection of Society, Politics, and Science." Croatian Medical Journal 52: 648-50.
28. Orlic, D., J. Kajstura, S. Chimenti, F. Limana, I. Jakoniuk, and F. Quaini. 2001. "Bone Marrow Cells Regenerate Infarcted Myocardium." Nature 410: 701-705.
29. Petersen, B., W. C. Bowen, K. D. Patrene, and W. M. Mars. 1999. "Bone Marrow as a Potential Source of Hepatic Oval Cells." Science 284: 1168-1170.
30. Rader, K. 2004. Making Mice: Standardizing Animals for American Biomedical Research, 1900-1955. Princeton, NJ: Princeton University Press.
31. RCUK (Research Councils UK). 2012. A Strategy for UK Regenerative Medicine. Swindon: Medical Research Council.
32. Rheinberger, H.-J. 1997. Toward a History of Epistemic Things: Synthesizing Proteins in the Test Tube. Stanford: Stanford University Press.
33. Rose, N. 2006. The Politics of Life Itself. Princeton, NJ: Princeton University Press.
34. Sager, M. 2006. Pluripotent Circulations: Putting Actor-Network Theory to Work on Stem Cells in the USA, Prior to 2001. Göteborg: Acta Universitatis Gothoburgensis.
35. Sleeboom-Faulkner, M. 2013. "Latent Science Collaboration: Strategic Cultures of Bioethical Capacity Building in Mainland China's Stem Cell World." Biosocieties 8 (32): 7-24.
36. Stephens, N., P. Atkinson, and P. Glasner. 2008. "The UK Stem Cell Bank as Performative Architecture." New Genetics and Society 27: 87-98.
37. The International Stem Cell Initiative Consortium. 2010. "Comparison of Defined Culture Systems for Feeder Cell Free Propagation of Human Embryonic Stem Cells." In Vitro Cellular & Developmental Biology - Animal 46: 247-258.
38. The International Stem Cell Initiative Consortium. 2011. "Screening Ethnically Diverse Human Embryonic Stem Cells Identifies a Chromosome 20 Minimal Amplicon Conferring Growth Advantage." Nature Biotechnology 29: 1133-1144.
39. Theise, N. D., M. Nimmakayalu, R. Gardner, P. B. Illei, G. Morgan, L. Teperman, O. Henegariu, Diane S. Krause. 2000. "Liver from Bone Marrow in Humans." Hepatology 32: 11-16.
40. Vermeulen, N., S. Tamminen, and A. Webster, eds. 2011. Bio-Objects: Life in the 21st Century. London: Ashgate.
41. Webster, A., and L. Eriksson. 2008. "Governance-by-Standards in the Field of Stem Cells: Managing Uncertainty in the World of 'Basic Innovation'." New Genetics and Society 27 (2): 99-111.
42. Webster, A., C. Haddad, and C. Waldby. 2011. "Experimental Heterogeneity and Standardisation: Stem Cell Products and the Clinical Trial Process." Biosocieties 6: 401-419.